FDA Warning Letter — Polaroisin International Co., Ltd.

Case 541792 — FEI 3008004582

The FDA took a Warning Letter action against Polaroisin International Co., Ltd. on Jan 26, 2018 (New Taipei City, Taiwan). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.

Action details

Facility
Polaroisin International Co., Ltd.
Date
Jan 26, 2018
Fiscal Year
2018
Product Type
Drugs
Center
CDER
Location
New Taipei City (Taiwan)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.